Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3) Peptide
-
- Target See all CHRNA3 products
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- EHRLFERLFE DYNEIIRPVA NVSDPVIIHF EVSMSQLVKV DEVNQIMETN
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA3 antibody,
Alternative Names: CHRNA3 control peptide, CHRNA3 antibody Blocking Peptide, Anti-CHRNA3 Blocking Peptide, Cholinergic Receptor Nicotinic Alpha 3 Blocking Peptide, MGC104879 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CHRNA3 (Cholinergic Receptor, Nicotinic, alpha 3 (Neuronal) (CHRNA3))
- Background
- The CHRNA3 subunit is expressed in the soma of the majority of pyramidal cells, with the most alpha 3 immunoreactivity observed in CA2-4 and entorhinal cortex and relatively less in CA1 and subicular pyramidal cell soma.
- Molecular Weight
- 57 kDa
-